Usama Malik

Usama Malik serves as Chief Financial Officer & Chief Business Officer at Immunomedics. Malik had been serving as the Company's interim Chief Financial Officer since August 2018, and the Company's Chief Business Officer since August 2017. Prior to joining the Company, Malik was the founder and managing partner of InnoAction Advisory Services, a boutique advisory firm with clients in the pharmaceutical and medical technologies fields, since January 2013. Prior to InnoAction, Malik was part of Senior Management at Bridgewater Associates from December 2011 to December 2012 and served as the Global Vice President of Strategy and Innovation at Pfizer from November 2007 through November 2011. Malik will remain the Company's Chief Business Officer. [Source: Public Company Filing]